KLF5 and breast cancer: It has been demonstrated that transcriptional coactivators downstream of the Hippo signaling pathway, including YAP/TAZ, promote the proliferation of breast cancer cells by stabilizing the KLF5 transcription factor, survival, and tumor growth, leading to poor prognosis of breast cancer (44).